ID   SO1B2_RAT               Reviewed;         687 AA.
AC   Q9QZX8; Q9JHF6; Q9JIM2;
DT   10-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   02-OCT-2024, entry version 175.
DE   RecName: Full=Solute carrier organic anion transporter family member 1B2;
DE   AltName: Full=Liver-specific organic anion transporter 1;
DE            Short=rLST-1;
DE   AltName: Full=Sodium-independent organic anion-transporting polypeptide 4;
DE            Short=OATP-4;
DE   AltName: Full=Solute carrier family 21 member 10;
GN   Name=Slco1b2; Synonyms=Oatp1b2, Slc21a10;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=10500057; DOI=10.1016/s0016-5085(99)70333-1;
RA   Kakyo M., Unno M., Tokui T., Nakagomi R., Nishio T., Iwasashi H., Nakai D.,
RA   Seki M., Suzuki M., Naitoh T., Matsuno S., Yawo H., Abe T.;
RT   "Molecular characterization and functional regulation of a novel rat liver-
RT   specific organic anion transporter rlst-1.";
RL   Gastroenterology 117:770-775(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 3).
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=10903899; DOI=10.1006/bbrc.2000.3105;
RA   Choudhuri S., Ogura K., Klaassen C.D.;
RT   "Cloning of the full-length coding sequence of rat liver-specific organic
RT   anion transporter-1 (rlst-1) and a splice variant and partial
RT   characterization of the rat lst-1 gene.";
RL   Biochem. Biophys. Res. Commun. 274:79-86(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=10838093; DOI=10.1016/s0014-5793(00)01596-9;
RA   Cattori V., Hagenbuch B., Hagenbuch N., Stieger B., Ha R.,
RA   Winterhalter K.H., Meier P.J.;
RT   "Identification of organic anion transporting polypeptide 4 (Oatp4) as a
RT   major full-length isoform of the liver-specific transporter-1 (rlst-1) in
RT   rat liver.";
RL   FEBS Lett. 474:242-245(2000).
RN   [4]
RP   CHARACTERIZATION.
RX   PubMed=11713643; DOI=10.1007/s004240100697;
RA   Cattori V., van Montfoort J.E., Stieger B., Landmann L., Meijer D.K.,
RA   Winterhalter K.H., Meier P.J., Hagenbuch B.;
RT   "Localization of organic anion transporting polypeptide 4 (Oatp4) in rat
RT   liver and comparison of its substrate specificity with Oatp1, Oatp2 and
RT   Oatp3.";
RL   Pflugers Arch. 443:188-195(2001).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16396499; DOI=10.1021/pr0503073;
RA   Moser K., White F.M.;
RT   "Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-
RT   MS/MS.";
RL   J. Proteome Res. 5:98-104(2006).
RN   [6]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND DOMAIN.
RX   PubMed=19129463; DOI=10.1152/ajpcell.00436.2008;
RA   Leuthold S., Hagenbuch B., Mohebbi N., Wagner C.A., Meier P.J., Stieger B.;
RT   "Mechanisms of pH-gradient driven transport mediated by organic anion
RT   polypeptide transporters.";
RL   Am. J. Physiol. 296:C570-C582(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-290; THR-660 AND SER-667, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Mediates the Na(+)-independent uptake of organic anions such
CC       as taurochlate, bromosulfophthalein and steroid conjugates (estrone 3-
CC       sulfate, 17-beta-glucuronosyl estradiol, dehydroepiandrosterone
CC       sulfate) (PubMed:19129463). Also transports prostaglandin E2 and L-
CC       thyroxine (T4) (PubMed:19129463). Shows a pH-sensitive substrate
CC       specificity which may be ascribed to the protonation state of the
CC       binding site and leads to a stimulation of substrate transport in an
CC       acidic microenvironment (PubMed:19129463). Hydrogencarbonate/HCO3(-)
CC       acts as the probable counteranion that exchanges for organic anions
CC       (PubMed:19129463). {ECO:0000269|PubMed:19129463}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=estrone 3-sulfate(out) = estrone 3-sulfate(in);
CC         Xref=Rhea:RHEA:71835, ChEBI:CHEBI:60050;
CC         Evidence={ECO:0000305|PubMed:19129463};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=taurocholate(out) = taurocholate(in); Xref=Rhea:RHEA:71703,
CC         ChEBI:CHEBI:36257; Evidence={ECO:0000305|PubMed:19129463};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=prostaglandin E2(out) = prostaglandin E2(in);
CC         Xref=Rhea:RHEA:50984, ChEBI:CHEBI:606564;
CC         Evidence={ECO:0000305|PubMed:19129463};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-thyroxine(out) = L-thyroxine(in); Xref=Rhea:RHEA:71819,
CC         ChEBI:CHEBI:58448; Evidence={ECO:0000305|PubMed:19129463};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=56.1 uM for estrone 3-sulfate (at pH 6.5)
CC         {ECO:0000269|PubMed:19129463};
CC         KM=91.7 uM for estrone 3-sulfate (at pH 8.0)
CC         {ECO:0000269|PubMed:19129463};
CC         KM=22.3 uM for taurocholate (at pH 6.5)
CC         {ECO:0000269|PubMed:19129463};
CC         KM=41.1 uM for taurocholate (at pH 8.0)
CC         {ECO:0000269|PubMed:19129463};
CC         KM=9.57 uM for prostaglandin E2 (at pH 6.5)
CC         {ECO:0000269|PubMed:19129463};
CC         KM=20 uM for prostaglandin E2 (at pH 8.0)
CC         {ECO:0000269|PubMed:19129463};
CC         Vmax=2164 pmol/min/mg enzyme with estrone 3-sulfate as substrate (at
CC         pH 6.5) {ECO:0000269|PubMed:19129463};
CC         Vmax=2332 pmol/min/mg enzyme with estrone 3-sulfate as substrate (at
CC         pH 8.0) {ECO:0000269|PubMed:19129463};
CC         Vmax=407 pmol/min/mg enzyme with taurocholate as substrate (at pH
CC         6.5) {ECO:0000269|PubMed:19129463};
CC         Vmax=475 pmol/min/mg enzyme with taurocholate as substrate (at pH
CC         8.0) {ECO:0000269|PubMed:19129463};
CC         Vmax=230 pmol/min/mg enzyme with prostaglandin E2 as substrate (at pH
CC         6.5) {ECO:0000269|PubMed:19129463};
CC         Vmax=205 pmol/min/mg enzyme with prostaglandin E2 as substrate (at pH
CC         8.0) {ECO:0000269|PubMed:19129463};
CC       pH dependence:
CC         Optimum pH is 6.5 with estrone 3-sulfate, taurocholate and
CC         prostaglandin E2 as substrates. {ECO:0000269|PubMed:19129463};
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane; Multi-pass membrane
CC       protein. Note=Confined to the basolateral plasma membrane of
CC       hepatocytes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=rLST-1a;
CC         IsoId=Q9QZX8-2; Sequence=Displayed;
CC       Name=2; Synonyms=rLST-1b;
CC         IsoId=Q9QZX8-1; Sequence=VSP_006150;
CC       Name=3; Synonyms=rLST-1c;
CC         IsoId=Q9QZX8-3; Sequence=VSP_006151;
CC   -!- TISSUE SPECIFICITY: Liver specific. Expression is highest in central
CC       perivenous hepatocytes and lowest in the periportal region. Isoform 1
CC       predominates. Not detected in heart, brain, kidney, skeletal muscle,
CC       lung, testis or spleen.
CC   -!- DOMAIN: A conserved histidine residue in the third TMD (His-115) may
CC       play an essential role in the pH sensitivity of SLCO1B2/OATP1B2-
CC       mediated substrate transport. {ECO:0000305|PubMed:19129463}.
CC   -!- SIMILARITY: Belongs to the organo anion transporter (TC 2.A.60) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF147740; AAF02526.1; -; mRNA.
DR   EMBL; AF208545; AAF87098.1; -; mRNA.
DR   EMBL; AF217450; AAF87099.1; -; mRNA.
DR   EMBL; AF272571; AAF90136.1; -; Genomic_DNA.
DR   EMBL; AF272558; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272559; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272560; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272561; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272562; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272563; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272564; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272565; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272566; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272567; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272568; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272569; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AF272570; AAF90136.1; JOINED; Genomic_DNA.
DR   EMBL; AJ271682; CAB92299.1; -; mRNA.
DR   RefSeq; NP_001257515.1; NM_001270586.1. [Q9QZX8-1]
DR   RefSeq; NP_001257516.1; NM_001270587.1. [Q9QZX8-3]
DR   RefSeq; NP_113838.1; NM_031650.3. [Q9QZX8-2]
DR   AlphaFoldDB; Q9QZX8; -.
DR   SMR; Q9QZX8; -.
DR   IntAct; Q9QZX8; 1.
DR   STRING; 10116.ENSRNOP00000013409; -.
DR   BindingDB; Q9QZX8; -.
DR   ChEMBL; CHEMBL1781861; -.
DR   TCDB; 2.A.60.1.8; the organo anion transporter (oat) family.
DR   GlyCosmos; Q9QZX8; 3 sites, No reported glycans.
DR   GlyGen; Q9QZX8; 3 sites.
DR   iPTMnet; Q9QZX8; -.
DR   PhosphoSitePlus; Q9QZX8; -.
DR   PaxDb; 10116-ENSRNOP00000013409; -.
DR   Ensembl; ENSRNOT00000013409.8; ENSRNOP00000013409.4; ENSRNOG00000030538.6. [Q9QZX8-2]
DR   Ensembl; ENSRNOT00000013514.7; ENSRNOP00000013514.4; ENSRNOG00000030538.6. [Q9QZX8-3]
DR   Ensembl; ENSRNOT00055017066; ENSRNOP00055013722; ENSRNOG00055010114. [Q9QZX8-2]
DR   Ensembl; ENSRNOT00060012952; ENSRNOP00060009827; ENSRNOG00060007844. [Q9QZX8-2]
DR   Ensembl; ENSRNOT00065018808; ENSRNOP00065014380; ENSRNOG00065011566. [Q9QZX8-2]
DR   GeneID; 58978; -.
DR   KEGG; rno:58978; -.
DR   UCSC; RGD:69300; rat. [Q9QZX8-2]
DR   AGR; RGD:69300; -.
DR   CTD; 28253; -.
DR   RGD; 69300; Slco1b2.
DR   eggNOG; KOG3626; Eukaryota.
DR   GeneTree; ENSGT01120000271841; -.
DR   HOGENOM; CLU_008954_4_0_1; -.
DR   InParanoid; Q9QZX8; -.
DR   OMA; KKTRYCN; -.
DR   OrthoDB; 2874223at2759; -.
DR   PhylomeDB; Q9QZX8; -.
DR   TreeFam; TF317540; -.
DR   Reactome; R-RNO-159418; Recycling of bile acids and salts.
DR   Reactome; R-RNO-189483; Heme degradation.
DR   Reactome; R-RNO-879518; Transport of organic anions.
DR   Reactome; R-RNO-9754706; Atorvastatin ADME.
DR   PRO; PR:Q9QZX8; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000030538; Expressed in liver and 9 other cell types or tissues.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0015125; F:bile acid transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0035673; F:oligopeptide transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015721; P:bile acid and bile salt transport; IDA:RGD.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0006811; P:monoatomic ion transport; IEA:UniProtKB-KW.
DR   GO; GO:0006857; P:oligopeptide transport; IDA:RGD.
DR   GO; GO:0034097; P:response to cytokine; IEP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0033993; P:response to lipid; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0043252; P:sodium-independent organic anion transport; IBA:GO_Central.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR036058; Kazal_dom_sf.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR004156; OATP.
DR   NCBIfam; TIGR00805; oat; 1.
DR   PANTHER; PTHR11388; ORGANIC ANION TRANSPORTER; 1.
DR   PANTHER; PTHR11388:SF89; SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 1B3; 1.
DR   Pfam; PF07648; Kazal_2; 1.
DR   Pfam; PF03137; OATP; 1.
DR   SUPFAM; SSF100895; Kazal-type serine protease inhibitors; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   PROSITE; PS51465; KAZAL_2; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..687
FT                   /note="Solute carrier organic anion transporter family
FT                   member 1B2"
FT                   /id="PRO_0000191052"
FT   TOPO_DOM        1..28
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        29..48
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        49..67
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        68..88
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        89..94
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        95..119
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        120..165
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        166..194
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        195..213
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        214..234
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        235..252
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        253..277
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        278..328
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        329..350
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        351..370
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        371..394
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        395..398
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        399..422
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        423..531
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        532..554
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        555..563
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        564..589
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        590..623
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        624..641
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        642..687
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          450..507
FT                   /note="Kazal-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   REGION          286..311
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        286..310
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         292
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JJL3"
FT   MOD_RES         660
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         667
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        134
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        496
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        511
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        456..486
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DISULFID        462..482
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DISULFID        471..505
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   VAR_SEQ         207..240
FT                   /note="GTLHTIAMIGPILGFIMSSVFAKIYVDVGYVDLN -> D (in isoform
FT                   3)"
FT                   /evidence="ECO:0000303|PubMed:10903899"
FT                   /id="VSP_006151"
FT   VAR_SEQ         407..441
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10500057"
FT                   /id="VSP_006150"
SQ   SEQUENCE   687 AA;  76767 MW;  E6A17786FD136CC6 CRC64;
     MDHTQQSRKA AEAQPSRSKQ TRFCDGFKLF LAALSFSYIC KALGGVVMKS SITQIERRFD
     IPSSISGLID GGFEIGNLLV IVFVSYFGSK LHRPKLIGIG CFIMGIGSIL TALPHFFMGY
     YKYAKENDIG SLGNSTLTCF INQMTSPTGP SPEIVEKGCE KGLKSHMWIY VLMGNMLRGI
     GETPIVPLGI SYLDDFAKEG HTSMHLGTLH TIAMIGPILG FIMSSVFAKI YVDVGYVDLN
     SVRITPNDAR WVGAWWLSFI VNGLLCITSS IPFFFLPKIP KRSQEERKNS VSLHAPKTDE
     EKKHMTNLTK QEEQDPSNMT GFLRSLRSIL TNEIYVIFLI LTLLQVSGFI GSFTYLFKFI
     EQQFGRTASQ ANFLLGIITI PTMATAMFLG GYIVKKFKLT SVGIAKFVFF TSSVAYAFQF
     LYFPLLCENK PFAGLTLTYD GMNPVDSHID VPLSYCNSDC SCDKNQWEPI CGENGVTYIS
     PCLAGCKSFR GDKKPNNTEF YDCSCISNSG NNSAHLGECP RYKCKTNYYF YIILQVTVSF
     FTAMGSPSLI LILMKSVQPE LKSLAMGFHS LIIRALGGIL APIYYGAFID RTCIKWSVTS
     CGKRGACRLY NSRLFGFSYL GLNLALKTPP LFLYVVLIYF TKRKYKRNDN KTLENGRQFT
     DEGNPDSVNK NGYYCVPYDE QSNETPL
//
